Does, Monique B.
Adams, Sara R.
Kline-Simon, Andrea H.
Marino, Catherine
Charvat-Aguilar, Nancy
Weisner, Constance M.
Rubinstein, Andrea L.
Ghadiali, Murtuza
Cowan, Penney
Young-Wolff, Kelly C.
Campbell, Cynthia I.
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (1310-08734, 1310-08734, 1310-08734, 1310-08734, 1310-08734, 1310-08734, 1310-08734, 1310-08734, 1310-08734, 1310-08734)
Article History
Received: 23 August 2023
Accepted: 3 January 2024
First Online: 22 January 2024
Declarations
:
: The study was approved by the institutional review board of Kaiser Permanente Northern California (1276529). All methods were performed in accordance with relevant institutional and federal guidelines and regulations. All study participants signed an informed consent form and authorization to use and disclose protected health information prior to participation.
: Not applicable.
: Two authors (MBD and CIC) have received grant support through their institution from the Industry PMR Consortium, a consortium of companies that conduct post marketing studies required by the Food and Drug Administration to assess risks related to opioid analgesic use. AR received payment for participation in the UC Davis Train the Trainer (mentoring) program; MG is a board member and chair (unpaid) for the Bay Area Physicians for Human Rights; and PC serves in a leadership role (unpaid) with World Patients Alliance. No other authors have competing interests to declare.